The effects of a topical analgesic and placebo in treatment of chronic knee pain

Journal of Aging and Physical Activity
J William MyrerGilbert W. Fellingham

Abstract

Chronic knee pain is a prevalent health problem of old and middle age. The authors' objective was to determine whether a topical analgesic would reduce knee pain and improve the function of a group of 40- to 65-year-old people with chronic knee pain. The experimental design was a double-blind, randomized, placebo-controlled clinical trial. The dependent variables were knee pain, active range of motion, and isometric strength. Forty-six men and women volunteered, of whom 3 dropped out, leaving 23 in the treatment group and 20 in the placebo group. Knee pain was assessed with a visual analogue scale and the knee-pain scale for frequency and severity. Testing took place before treatment and after 21 and 35 days of treatment. The results indicated that although both groups experienced improved pain scores, there were no differences between groups over the treatment period for any of the dependent variables.

References

Mar 1, 1992·British Journal of Rheumatology·T E McAlindonP A Dieppe
Apr 1, 1992·British Journal of Clinical Pharmacology·A C Jones, M Doherty
May 1, 1987·Physical Therapy·D L RiddleR L Lamb
Nov 19, 1965·Science·R Melzack, P D Wall
Feb 1, 1970·Physical Therapy·J R White, J N Sage
Oct 1, 1993·The Journal of Bone and Joint Surgery. American Volume·J A BuckwalterD R Eyre
Nov 1, 1996·Medicine and Science in Sports and Exercise·J H RimmerK H Pitetti
Sep 24, 1999·Pain·R Melzack
Sep 24, 1999·Current Medical Research and Opinion·N BellamyJ Syrotuik
Nov 26, 1999·Rheumatic Diseases Clinics of North America·E D Rosenstein
Mar 19, 2002·Neuroscience Letters·Nicoletta GaleottiCarla Ghelardini
Feb 1, 1989·The Physician and Sportsmedicine·J Barone

❮ Previous
Next ❯

Citations

Jun 28, 2007·The Nurse Practitioner·Bill McCarberg, Yvonne D'Arcy
Feb 5, 2013·Mayo Clinic Proceedings·Charles E Argoff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.